SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001136261-17-000264
Filing Date
2017-11-07
Accepted
2017-11-07 16:02:33
Documents
4
Period of Report
2017-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K body8k.htm 8-K 11558
2 PRESS RELEASE exh99-1.htm EX-99.1 164953
3 LOGO image1904.jpg GRAPHIC 6415
4 LOGO image2388.gif GRAPHIC 6297
  Complete submission text file 0001136261-17-000264.txt   195661
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14494 | Film No.: 171183343
SIC: 2834 Pharmaceutical Preparations